Victoria Baltrus Sells 8,078 Shares of Oscar Health, Inc. (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) CAO Victoria Baltrus sold 8,078 shares of the firm’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $146,050.24. Following the transaction, the chief accounting officer now directly owns 146,036 shares of the company’s stock, valued at $2,640,330.88. The trade was a 5.24 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Oscar Health Trading Down 3.3 %

Shares of OSCR stock opened at $16.40 on Friday. Oscar Health, Inc. has a fifty-two week low of $7.50 and a fifty-two week high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The stock has a 50 day simple moving average of $17.08 and a two-hundred day simple moving average of $17.93. The company has a market cap of $4.06 billion, a P/E ratio of -273.33 and a beta of 1.63.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The company had revenue of $2.42 billion during the quarter, compared to the consensus estimate of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The business’s revenue was up 68.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.29) EPS. Research analysts forecast that Oscar Health, Inc. will post -0.01 earnings per share for the current year.

Hedge Funds Weigh In On Oscar Health

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. KBC Group NV raised its stake in Oscar Health by 41.2% during the 3rd quarter. KBC Group NV now owns 4,552 shares of the company’s stock worth $97,000 after buying an additional 1,328 shares during the period. Point72 Hong Kong Ltd bought a new stake in shares of Oscar Health during the second quarter valued at approximately $78,000. Quest Partners LLC acquired a new position in shares of Oscar Health during the second quarter worth approximately $93,000. Optimum Investment Advisors acquired a new position in shares of Oscar Health during the third quarter worth approximately $142,000. Finally, Amalgamated Bank lifted its holdings in shares of Oscar Health by 27.7% in the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after purchasing an additional 1,458 shares in the last quarter. Institutional investors own 75.70% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently issued reports on OSCR. Bank of America lowered Oscar Health from a “neutral” rating to an “underperform” rating and lowered their target price for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th. UBS Group started coverage on Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 price objective on the stock. Finally, Piper Sandler reiterated an “overweight” rating and issued a $28.00 target price on shares of Oscar Health in a report on Tuesday, September 10th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $22.93.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.